Editor's Choice
Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call20 Mar 2023
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced it has cancelled... Continue Reading
|
University of Queensland’s Aphasia Treatment Programme Goes Online13 Mar 2023
The University of Queensland is now expanding its aphasia therapy programme to reach more patients living in rural and regional... Continue Reading
|
WeightWatchers Moves Into Obesity Drug Market with Sequence Purchase13 Mar 2023
Weightwatchers announced plans to buy telehealth platform Weekend Health, also known as Sequence, in a move toward offering prescription weight... Continue Reading
|
VA Telehealth Expansion Lagged in Rural Areas During COVID-1913 Mar 2023
A digital divide in telemedicine use between rural and urban communities increased after the onset of the COVID-19 pandemic, particularly... Continue Reading
|
A Smarter Approach to Commercial Ecosystems for Superior HCP Experiences13 Mar 2023
The commercial life science industry continues to undergo a radical shift in the way it interacts with healthcare providers (HCPs)... Continue Reading
|
Orthofix Medical Reports Orthofix and Seaspine Fourth Quarter and Full-Year 2022 Results13 Mar 2023
The merger of Orthofix Medical Inc. (“Orthofix”) and SeaSpine Inc. (“SeaSpine”) became effective as of January 5, 2023. This news... Continue Reading
|
Thai Researchers Develop AI for Assessing Stroke Risk and More Briefs07 Mar 2023
Chulalongkorn University researchers develop AI to assess stroke risk A research team from the Medicine and Engineering faculties of Chulalongkorn... Continue Reading
|
FTC Action on Health Data Sharing Could Put Digital Health ’On Notice’07 Mar 2023
The Federal Trade Commission has started cracking down on digital health companies for allegedly sharing consumers’ health data for advertising... Continue Reading
|
Color Announces Layoffs as It Rolls Back Covid-19 Testing07 Mar 2023
Population health technology company Color announced it had laid off workers as it pivots focus away from COVID-19 testing. According... Continue Reading
|
Australia’s TGA clears TALi’s new attention training device and more briefs07 Mar 2023
TALi obtains Australia’s nod for cognitive attention trainer device TALi Digital, an ASX-listed developer of diagnostic and therapeutic tools for... Continue Reading
|